arrow_back Trending Legislation
Share share

New Sickle Cell Treatment Centers: Better, Coordinated Lifelong Healthcare Access

This law establishes a nationwide network of specialized Sickle Cell Disease Treatment Centers using a "hub-and-spoke" model. The goal is to ensure patients have access to coordinated, comprehensive medical care throughout their lives, including advanced therapies and social support. Citizens affected by this disease will gain better access to specialists, assistance with insurance, and help addressing daily challenges like transportation or food insecurity.
Key points
Creation of "hub-and-spoke" networks to deliver comprehensive care, including stem cell transplants and gene therapies, led by specialized medical centers.
Implementation of programs to improve the transition of patients from pediatric to adult care, ensuring continuity of treatment.
Funding for assistance with accessing health insurance, social services, genetic counseling, and transportation for patients.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Sickle Cell Disease Treatment Centers Act of 2024
Print number: S 5226
Sponsor: Sen. Van Hollen, Chris [D-MD]
Process start date: 2024-09-25
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about New Sickle Cell Treatment Centers: Better, Coordinated Lifelong Healthcare Access

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 5226.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2024-09-25.

What are the main provisions?

Key points include:

  • Creation of "hub-and-spoke" networks to deliver comprehensive care, including stem cell transplants and gene therapies, led by specialized medical centers.
  • Implementation of programs to improve the transition of patients from pediatric to adult care, ensuring continuity of treatment.
  • Funding for assistance with accessing health insurance, social services, genetic counseling, and transportation for patients.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Van Hollen, Chris [D-MD].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

Analysis and Potential Impact of S 5226

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health